Press Releases
🇪🇺 EMA Page 4EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 37–48 of 121 articles
Novo Nordisk Presents New Wegovy Data for Women with Obesity at European Congress on Obesity 2026
Solid Biosciences Receives European Orphan Drug Designation for SGT-003 Duchenne Muscular Dystrophy Treatment
Cytokinetics MYQORZO (Aficamten) Takes Center Stage at European Society of Cardiology Heart Failure 2026 Congress
Artiva Biotherapeutics' AlloNK Receives FDA Fast Track Designation for Refractory Rheumatoid Arthritis Treatment
SQ Innovation's Lasix ONYU Receives CE Marking Approval, Advances Toward European Market Authorization
Elanco's Negasunt and Tanidil Receive FDA Emergency Authorization for New World Screwworm Treatment in Livestock
Opella's Essentiale Shows 2.5x Greater Liver Fat Reduction in Breakthrough EXCEL Trial for Fatty Liver Disease
Advanced Bifurcation Systems Acquires Svelte Medical Systems in Major Coronary Stent Deal
Zentiva Appeals EU Court Decision on Urban Wastewater Directive Affecting Generic Medicine Access
AB Science Secures Loan Repayment Deferrals to Fund R&D Operations Through 2028
Mundipharma's REZZAYO (Rezafungin) Meets Primary Endpoint in Phase III ReSPECT Trial for Fungal Disease Prevention
Boston Scientific Corporation Faces Securities Class Action Lawsuit with May 4 Deadline for Investors